Terrie Curran - Jul 15, 2024 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role
President and Chief Executive, Director
Signature
/s/ Molly Henderson, Attorney-in-Fact for Terrie Curran
Stock symbol
PHAT
Transactions as of
Jul 15, 2024
Transactions value $
-$396,699
Form type
4
Date filed
7/17/2024, 02:50 PM
Previous filing
Jun 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHAT Common Stock Sale -$397K -33.8K -8.22% $11.72 378K Jul 15, 2024 Direct F1, F2
holding PHAT Common Stock 3.84K Jul 15, 2024 By 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.
F2 Includes 798 shares acquired under the Phathom Pharmaceuticals, Inc. employee stock purchase plan in July 2024.